Qingdao Haier Biomedical Co.,Ltd Stock price

Equities

688139

CNE100003P25

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
28.31 CNY +2.20% Intraday chart for Qingdao Haier Biomedical Co.,Ltd -10.07% -30.13%
Sales 2023 2.28B 316M Sales 2024 * 3.42B 473M Capitalization 8.96B 1.24B
Net income 2023 406M 56.18M Net income 2024 * 749M 104M EV / Sales 2023 5.62 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 2.62 x
P/E ratio 2023
31.7 x
P/E ratio 2024 *
12 x
Employees 2,690
Yield 2023 *
-
Yield 2024 *
-
Free-Float 49.74%
More Fundamentals * Assessed data
Dynamic Chart
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Qingdao Haier Biomedical Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares. CI
Qingdao Haier Biomedical Co.,Ltd authorizes a Buyback Plan. CI
CICC Elects Chairman, Vice Chairman MT
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 80 Yuan From 100 Yuan, Keeps at Buy MT
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jefferies Adjusts Qingdao Haier Biomedical's Price Target to 100 Yuan From 120 Yuan, Keeps at Buy MT
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Chaoli'an Technology Co., Ltd. announced that it expects to receive CNY 43 million in funding from Qingdao Haier Biomedical Co.,Ltd CI
Qingdao Haier Biomedical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 120 Yuan From 126 Yuan, Keeps at Buy MT
Qingdao Haier Biomedical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022. CI
Qingdao Haier Biomedical Co., Ltd's Equity Buyback announced on February 7, 2022, has expired with 1,459,586 shares, representing 0.46% for CNY 99.69 million. CI
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022. CI
More news
1 day+2.20%
1 week-10.07%
Current month-9.55%
1 month-12.38%
3 months-24.18%
6 months-28.40%
Current year-30.13%
More quotes
1 week
27.70
Extreme 27.7
30.90
1 month
27.70
Extreme 27.7
32.84
Current year
25.50
Extreme 25.5
42.49
1 year
25.50
Extreme 25.5
75.50
3 years
25.50
Extreme 25.5
150.88
5 years
23.87
Extreme 23.87
150.88
10 years
23.87
Extreme 23.87
150.88
More quotes
Managers TitleAgeSince
Founder 54 05-10-27
Director of Finance/CFO 43 18-12-31
Chief Tech/Sci/R&D Officer 65 05-09-30
Members of the board TitleAgeSince
Director/Board Member 58 18-05-31
Director/Board Member 52 18-02-28
Founder 54 05-10-27
More insiders
Date Price Change Volume
24-03-27 28.31 +2.20% 2 189 388
24-03-27 27.7 -2.19% 1,632,803
24-03-26 28.32 -1.53% 1,498,149
24-03-25 28.76 -3.00% 1,854,644
24-03-22 29.65 -3.67% 2,154,170

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
Qingdao Haier Biomedical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of biomedical cryogenic storage products. The Company's main businesses include biological sample libraries, drug and reagent safety, blood safety, vaccine safety and third-party laboratory products. The Company's main products include ultra-low temperature freezer, low temperature freezer, thermostat refrigerators and biosafety cabinets. The Company distributes its products both in the domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
28.31 CNY
Average target price
65 CNY
Spread / Average Target
+129.60%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Qingdao Haier Biomedical Co.,Ltd - Shanghai S.E.